These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 22358396

  • 21. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.
    Jones RN, Low DE, Pfaller MA.
    Diagn Microbiol Infect Dis; 1999 Feb; 33(2):101-12. PubMed ID: 10091033
    [Abstract] [Full Text] [Related]

  • 22. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [Abstract] [Full Text] [Related]

  • 23. Bacteremia in febrile cancer patients in Uganda.
    Lubwama M, Phipps W, Najjuka CF, Kajumbula H, Ddungu H, Kambugu JB, Bwanga F.
    BMC Res Notes; 2019 Jul 30; 12(1):464. PubMed ID: 31362783
    [Abstract] [Full Text] [Related]

  • 24. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2008 May 30; 61(1):86-95. PubMed ID: 18385000
    [Abstract] [Full Text] [Related]

  • 25. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2007 May 30; 58(1):19-26. PubMed ID: 17383139
    [Abstract] [Full Text] [Related]

  • 26. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.
    Cohen B, Liu J, Larson E.
    J Prev Med Hyg; 2017 Dec 30; 58(4):E294-E301. PubMed ID: 29707660
    [Abstract] [Full Text] [Related]

  • 27. Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control.
    Reale M, Strazzulla A, Quirino A, Rizzo C, Marano V, Postorino MC, Mazzitelli M, Greco G, Pisani V, Costa C, Cesana BM, Liberto MC, Torti C, Focà A.
    Infez Med; 2017 Jun 01; 25(2):98-107. PubMed ID: 28603227
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
    Fritsche TR, Sader HS, Stillwell MG, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Apr 01; 63(4):440-6. PubMed ID: 19302928
    [Abstract] [Full Text] [Related]

  • 29. Epidemiology of blood stream infections in pediatric patients at a Tertiary Care Cancer Centre.
    Thacker N, Pereira N, Banavali SD, Narula G, Vora T, Chinnaswamy G, Prasad M, Kelkar R, Biswas S, Arora B.
    Indian J Cancer; 2014 Apr 01; 51(4):438-41. PubMed ID: 26842152
    [Abstract] [Full Text] [Related]

  • 30. Current status of carbapenemases in Latin America.
    Maya JJ, Ruiz SJ, Blanco VM, Gotuzzo E, Guzman-Blanco M, Labarca J, Salles M, Quinn JP, Villegas MV.
    Expert Rev Anti Infect Ther; 2013 Jul 01; 11(7):657-67. PubMed ID: 23879607
    [Abstract] [Full Text] [Related]

  • 31. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM, Jones RN, Sader HS, Fritsche TR.
    Int J Antimicrob Agents; 2004 Aug 01; 24(2):111-8. PubMed ID: 15288308
    [Abstract] [Full Text] [Related]

  • 32. Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
    Fraise AP.
    J Med Microbiol; 1997 Jun 01; 46(6):447-9. PubMed ID: 9379471
    [No Abstract] [Full Text] [Related]

  • 33. Results of the national surveillance of antimicrobial resistance of Enterobacteriaceae and Gram negative bacilli in health care-associated infections in Colombia, 2012-2014.
    Ovalle MV, Saavedra SY, González MN, Hidalgo AM, Duarte C, Beltrán M.
    Biomedica; 2017 Dec 01; 37(4):473-485. PubMed ID: 29373768
    [Abstract] [Full Text] [Related]

  • 34. [The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation].
    Martínez-Martínez L, Calvo J.
    Enferm Infecc Microbiol Clin; 2010 Sep 01; 28 Suppl 2():25-31. PubMed ID: 21130927
    [Abstract] [Full Text] [Related]

  • 35. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL, Yang ZC, Yin SP, Liu MX, Zhang C, Luo XQ, Peng YZ.
    Zhonghua Shao Shang Za Zhi; 2016 Sep 20; 32(9):529-35. PubMed ID: 27647068
    [Abstract] [Full Text] [Related]

  • 36. Pattern of Polymicrobial Isolates and Antimicrobial Susceptibility from Blood.
    Shabbir S, Jamil S, Hafiz S.
    J Coll Physicians Surg Pak; 2016 Jul 20; 26(7):585-8. PubMed ID: 27504550
    [Abstract] [Full Text] [Related]

  • 37. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN, Kirby JT, Rhomberg PR.
    Diagn Microbiol Infect Dis; 2008 Jun 20; 61(2):203-13. PubMed ID: 18329835
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R, Noriega ER, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2015 Dec 15; 14():53. PubMed ID: 26667651
    [Abstract] [Full Text] [Related]

  • 39. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
    Jones RN, Ross JE, Bell JM, Utsuki U, Fumiaki I, Kobayashi I, Turnidge JD.
    Diagn Microbiol Infect Dis; 2009 Dec 15; 65(4):404-13. PubMed ID: 19913683
    [Abstract] [Full Text] [Related]

  • 40. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul 15; 52(3):187-93. PubMed ID: 16105563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.